These U.S. Retail Stocks are Practically Immune to European Woes

These U.S. Retail Stocks are Practically Immune to European Woes

Research  these Stocks on Kapitall’s Playground Now

research now

With continued turmoil, bailouts, and endless new rounds of parliamentary elections taking place almost daily in Europe, investors want to find assets that are not exposed to the economic uncertainty in the region.

We began a search in the retail sector for firms that have exposure solely in the U.S. marketplace and show potential for further growth.

Ultimately we found three companies whose share prices have benefitted from consumer behavior in America as well as consistent and steady dividend distribution.

Our Top Picks

The first of these is Dollar Tree, Inc. (DLTR).  Renowned as a center for discount retailing and a place that consumers turn to in difficult economic times, this company has benefitted from the economic stagnation that has become apparent over the past few months.  The dollar store franchise’s stock is up over twenty percent this calendar year, and with consumers still unsure as to whether or not the economy is gaining steam, it is likely they will continue to frequent this retailer in large numbers.

Walgreen’s (WAG) is another company in this sector who is presenting itself as an attractive buy right now.  After its share price took a decline following a conflict with its prescription provider, Express Scripts (ESRX), at the beginning of this year, the stock now offers itself at an reasonable price point with remaining room for growth.  The share price currently hovers just above the fifty-two week low, yet the company still displays a sound balance sheet and pays out a healthy 2.9% dividend yield.  Between these factors and because Walgreen’s derives one-hundred percent of their revenue from the United States, average analysts rate it as a moderate buy.

The final retailer we found who is totally reliant on business in the United States is CVS Caremark (CVS).  After gaining business from the customers Walgreen’s lost in the early part of 2012, CVS saw a fourteen-percent rise in revenues over the same time.  As competitors like RiteAid (RAD) are likely to struggle going forward and Walgreen’s has an unorganized prescription business, it would appear that CVS will maintain a competitive advantage in the mid-price retail business along with freedom from European problems.

Business Section: Investing Ideas

With a lack of exposure to European markets all of the names mentioned above offer different advantages and opportunities to operate in a sound environment.

Listed below in more detail are each of the aforementioned stocks.

Interactive Chart: Use the Compar-O-Matic to compare analyst ratings for the stocks mentioned below:

“1. Dollar Tree, Inc. (DLTR, Earnings, Analysts, Financials): Operates discount variety stores in the United States and Canada. Market cap at $12.26B, most recent closing price at $105.73.



“2. CVS Caremark Corporation (CVS, Earnings, Analysts, Financials): Operates as a pharmacy services company in the United States. Market cap at $57.32B, most recent closing price at $44.73.



“3. Walgreen Co. (WAG, Earnings, Analysts, Financials): Engages in the operation of a chain of drugstores in the United States. Market cap at $26.94B, most recent closing price at $31.22.



“4. Rite Aid Corp. (RAD, Earnings, Analysts, Financials): Operates retail drugstores in the United States. Market cap at $1.06B, most recent closing price at $1.18.



(Written by Dan Connelly)


Use Kapitall's Tools: Looking for ways to analyze this list?

Use this article snapshot as a launch pad (click here for help): Simply click on the links, and use Kapitall's tab navigation to browse through the data…


Analyze These Ideas: Getting Started

Dig Deeper: Access Company Snapshots, Charts, Filings

New to Kapitall?

1. New to the site? Click here to register for a free account, and gain access to more tools and data
2. Looking for more investing ideas like this? Click here to sign up for your free copy of Kapitall Weekly
3. Follow us on SeekingAlpha, Motley Fool, Nasdaq and Twitter




Kapitall Wire, which is not a broker/dealer, offers free cutting edge investing ideas, lively commentary and timely analysis of companies enhanced by interactive tools. And the Investing 101 section breaks complex concepts down to their basics, offering education to novices that doubles as a refresher course for more seasoned investors.

Kapitall Wire is a division of Kapitall Inc. Securities products and services are offered by Kapitall Generation, LLC, member FINRA/SIPC . Kapitall Generation, LLC is a wholly owned subsidiary of Kapitall, Inc.



2 responses to “These U.S. Retail Stocks are Practically Immune to European Woes”

  1. No stock is totally immune to a European meltdown.

  2. disclosure: I don't own any of the stocks listed right now.

Leave a Reply

Your email address will not be published. Required fields are marked *

  • See Most Recent Articles